Study on Delayed Graft Function Using Paired Kidneys

Phase 2 Unknown 12 enrolled Angion Biomedica Corp National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is designed to evaluate the safety and efficacy of an intravenously administered drug in recipients of kidneys from cardiac death donors who are risk for developing delayed graft function.

Timeline

Start: 2011-08
Primary completion: 2016-02
Completion: 2016-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	BB3	Small molecule	2 mg/kg	Intravenous

Indications

No indication recorded.